Correlation Between Salarius Pharmaceuticals and Histogen

Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salarius Pharmaceuticals and Histogen, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Histogen.

Diversification Opportunities for Salarius Pharmaceuticals and Histogen

0.44

Correlation Coefficient

Salarius Pharmaceuticals  Histogen

Very weak diversification

The 3 months correlation between Salarius and Histogen is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Histogen go up and down completely randomly.

Pair Corralation between Salarius Pharmaceuticals and Histogen

Given the investment horizon of 90 days Salarius Pharmaceuticals is expected to generate 0.4 times more return on investment than Histogen. However, Salarius Pharmaceuticals is 2.5 times less risky than Histogen. It trades about 0.02 of its potential returns per unit of risk. Histogen is currently generating about -0.11 per unit of risk. If you would invest  150.00  in Salarius Pharmaceuticals on August 31, 2024 and sell it today you would lose (3.00) from holding Salarius Pharmaceuticals or give up 2.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

Salarius Pharmaceuticals  vs.  Histogen

Salarius Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Salarius Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Salarius Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Histogen

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Salarius Pharmaceuticals and Histogen

The main advantage of trading using opposite Salarius Pharmaceuticals and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.

The idea behind Salarius Pharmaceuticals and Histogen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.